Integrase Inhibitors, From Drug Discovery to Clinical Practice


Integrase strand transfer inhibitors (InSTIs) present a novel mechanism without cross resistance to other, licensed ARVs.
The mechanism of InSTI resistance explains the substantial cross resistance observed among diverse InSTIs.
InSTIs exhibit a prolonged window for intervention and a long intracellular residence time. These have implications for understanding PK/PD and for potential use in PREP and PEP?

Autor und Referent

Dr. Daria Hazuda

Dr. Hazuda is Vice-President; Worldwide Basic Research Head for Antivirals
at the Merck Research Labs.


Technische Voraussetzungen

  • Software: Adobe Flash Plugin (Player) ab Version 7.
    Versions-Abfrage und Verlinkung zur Player-Installation erfolgt automatisch.
  • Bandbreite: Die Filme sind über eine schnelle Modemverbindung, ISDN oder DSL/Standleitung zu sehen.

Bei technischen Fragen, wenden Sie sich bitte an

 Back to Top

Valid XHTML 1.0 Transitional